Is STAB or GBDC a better dividend investment in 2026?

STAB currently yields 500000.00% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: STAB offers higher current income.

What is the dividend yield difference between STAB and GBDC?

STAB has a forward dividend yield of 500000.00% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 499988.14 percentage points.

Home › Compare › STAB vs GBDC

STAB vs GBDC: Dividend Comparison 2026

STAB yields 500000.00% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 STAB wins by $4.663521010693878e+33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

STAB

● Live price

500000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.663521010693878e+33M

Annual income

$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00

Full STAB calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — STAB vs GBDC

📍 STAB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	STAB	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, STAB + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

STAB pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STAB

Annual income on $10K today (after 15% tax)

$42,500,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, STAB beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STAB + GBDC for your $10,000?

STAB: 50%GBDC: 50%

100% GBDC50/50100% STAB

Portfolio after 10yr

$2.331760505346939e+33M

Annual income

$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

STAB

No analyst data

Altman Z

-22.8

Piotroski

4/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STAB buys

GBDC buys

No recent congressional trades found for STAB or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSTABGBDC

Forward yield	500000.00% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$4.663521010693878e+33M	$20.85M ✓
Annual income after 10y	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓	$16,450,733.83
Total dividends collected	$4.6634009849658873e+33M	$20.43M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: STAB vs GBDC ($10,000, DRIP)

Year	STAB Portfolio	STAB Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$50,010,700	$50,000,000.00	$12,492	$1,791.70	+$50.00M → STAB
2	$233,748,371,262	$233,694,859,813.08	$16,527	$3,160.58	+$233748.35M → STAB
3	$1,021,074,511,412,696	$1,020,824,400,655,446.10	$23,588	$5,904.90	+$1021074511.39M → STAB
4	$4,168,597,328,794,951,700	$4,167,504,779,067,739,000.00	$37,141	$11,901.65	+$4168597328794.91M → STAB
5	$15,905,475,114,600,665,000,000	$15,901,014,715,458,854,000,000.00	$66,205	$26,463.38	+$15905475114600664.00M → STAB
6	$56,718,938,532,531,060,000,000,000	$56,701,919,674,158,435,000,000,000.00	$137,452	$66,612.65	+$56718938532531060736.00M → STAB
7	$189,031,807,435,623,860,000,000,000,000	$188,971,118,171,394,040,000,000,000,000.00	$342,372	$195,298.53	+$1.8903180743562385e+23M → STAB
8	$588,799,810,476,518,260,000,000,000,000,000	$588,597,546,442,562,100,000,000,000,000,000.00	$1,053,292	$686,954.33	+$5.8879981047651824e+26M → STAB
9	$1,714,064,268,114,722,600,000,000,000,000,000,000	$1,713,434,252,317,512,700,000,000,000,000,000,000.00	$4,111,439	$2,984,416.95	+$1.7140642681147225e+30M → STAB
10	$4,663,521,010,693,878,300,000,000,000,000,000,000,000	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00	$20,849,974	$16,450,733.83	+$4.663521010693878e+33M → STAB

STAB vs GBDC: Complete Analysis 2026

STAB — Stock

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.

Full STAB Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this STAB vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STAB vs SCHD STAB vs JEPI STAB vs O STAB vs KO STAB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.